Literature DB >> 25126475

Collect Data, Tell Stories: Utilizing Available Data to Improve Wound Product Selection, Reduce Costs, and Improve Outcomes.

Eliot Mostow1, Jon D Montemayor2, Sean Pittinger3, Stephannie Miller1, Kimberly N Blasiole1, Judith Fulton1.   

Abstract

Objective: To develop a tool to assist in the evaluation of treatment options based on clinically relevant parameters, thus enabling clinicians to heal patients more efficiently. Approach: Outlined here is the prototypic model of a comprehensive analysis tool to compare products by category, accounting for product characteristics, effectiveness data from literature, costs, and patient needs or clinician preferences.
Results: The tool is demonstrated with a venous leg ulcer example, and ideas for expanding the tool in the future are provided. Innovation: Although this is a simple model, the authors believe that it provides a valid and useful platform for comparing similar products of a given type using available information and reflecting real-world use to give a practical approach to clinical decision-making.
Conclusion: Future funding for comprehensive, comparative effectiveness studies should provide clarity on which products to choose for specific applications. Meanwhile, tools like this can provide guidance, and can be modified to accommodate varying circumstances.

Entities:  

Year:  2014        PMID: 25126475      PMCID: PMC4121051          DOI: 10.1089/wound.2012.0425

Source DB:  PubMed          Journal:  Adv Wound Care (New Rochelle)        ISSN: 2162-1918            Impact factor:   4.730


  6 in total

1.  Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial.

Authors:  Eliot N Mostow; G Davin Haraway; Michael Dalsing; Jason P Hodde; Dennis King
Journal:  J Vasc Surg       Date:  2005-05       Impact factor: 4.268

2.  A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers.

Authors:  V Falanga; M Sabolinski
Journal:  Wound Repair Regen       Date:  1999 Jul-Aug       Impact factor: 3.617

3.  Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.

Authors:  A Veves; V Falanga; D G Armstrong; M L Sabolinski
Journal:  Diabetes Care       Date:  2001-02       Impact factor: 19.112

4.  Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers.

Authors:  Jeffrey A Niezgoda; Carl C Van Gils; Robert G Frykberg; Jason P Hodde
Journal:  Adv Skin Wound Care       Date:  2005-06       Impact factor: 2.347

5.  The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial.

Authors:  William A Marston; Jason Hanft; Paul Norwood; Richard Pollak
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

6.  Treatment of venous leg ulcers with Dermagraft.

Authors:  A A Omar; A I D Mavor; A M Jones; S Homer-Vanniasinkam
Journal:  Eur J Vasc Endovasc Surg       Date:  2004-06       Impact factor: 7.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.